At a glance
ClinicalIndex Comparison RecordN/ACompleted· 272 enrolled
Drug / intervention
PureVision Multi-Focal contact lenses +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers
In Brief
A clinical study evaluating PureVision Multi-Focal contact lenses and SofLens59 contact lens for Vision Disorders. Completed, enrolled 272 participants across 1 site.
Detailed Summary
This study is being conducted to evaluate Bausch \& Lomb PureVision Multi-Focal contact lenses compared to the Bausch \& Lomb SofLens59 contact lens when worn by adapted soft contact lens wearers on a daily wear basis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVision Disorders
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2009
First PostedSep 2009
Primary CompletionNov 2009
Study CompletionDec 2009
TodayJul 2026
First PostedSep 28, 2009
Enrollment StartSep 1, 2009
Primary CompletionNov 1, 2009
Study CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.8 years ago
Interventions
PureVision Multi-Focal contact lensesdevice
Contact lenses to be worn on a daily wear basis for 2 weeks.
SofLens59 contact lensdevice
Contact lenses to be worn on a daily wear basis for 2 weeks.